The panel consisted of both general cell structure markers such as Hoechst and Lamin for nuclear staining, as well as specific breast cancer subtype markers such as multiple cytokeratins, estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2). The gene discussed is ERBB2; the disease is breast carcinoma.